Melrose FutureLab Inflammation modulator helps to relieve symptoms of mild arthritis and reduces mild joint aches and pains.
Melrose FutureLab Inflammation modulator is a premium quality formula featuring Meriva® Curcuma longa phospholipid complex, a patented and clinically trialled form of curcumin.

Melrose FutureLab Inflammation modulator also contains Levagen+ is a bioavailability-enhanced form of Palmitoylethanolamide (PEA), a fatty acid that belongs to the family of endocannabinoids. 

The formula leverages both Phytosomal and LipiSperse technologies, active ingredient delivery systems designed to enhance absorption rates and optimise bioavailability within the body.